Target intelligence / Profile preview

MicroRNA 135a-5p target messenger RNAs (miR-135a-5p targets)

Target
miR-135a-5p targets
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

MicroRNA 135a-5p (miR-135a-5p) target messenger RNAs (mRNAs) represent a diverse population of transcripts regulated by the miR-135a-5p microRNA through sequence-specific binding to their 3' untranslated regions (3'UTRs). This regulatory interaction typically results in the degradation of the target mRNA or the inhibition of its translation, thereby modulating the expression of proteins involved in critical cellular pathways (Chen et al., 2019, Aging [PMID: 31175145]). miR-135a-5p has been identified as a key regulator in various diseases, acting as a tumor suppressor in some contexts by targeting oncogenes like ROCK1 and JAK2, or as an oncomir in others by targeting tumor suppressors like APC (Chen et al., 2019, Oncology Reports [PMID: 30628693]; Zhou et al., 2017, Biomedical Reports [PMID: 28663875]). In neurodegenerative conditions such as Alzheimer's disease, miR-135a-5p targets SIRT1, influencing amyloid-beta production and neuronal survival (Chen et al., 2019, Aging [PMID: 31175145]). Therapeutic intervention strategies involve the use of synthetic miR-135a-5p mimics to restore its function or antagomirs to inhibit its activity, depending on the disease state. The "other" seed-matched targets refer to the broader network of mRNAs that may be affected by such therapies, necessitating careful evaluation of off-target effects and systemic safety.

Other names
miR-135a-5p seed-matched 3'UTRshsa-miR-135a-5p targetsmiR-135a-5p regulated transcriptsmiR-135a-5p binding sites
02

Mechanism of action

MicroRNA mimics or antagomirs modulate the expression of these targets by either supplementing the endogenous miRNA pool to enhance silencing or sequestering the miRNA to prevent it from binding to the 3'UTRs of these mRNAs.

03

Biological functions

Post-transcriptional gene silencingmRNA degradationTranslational inhibitionCell proliferationApoptosisSignal transduction
04

Disease associations

CancerNeurodegenerative diseaseEndometriosisCardiovascular diseaseMetabolic disorder
05

Safety considerations

Off-target gene silencing of non-disease-related transcriptsSaturation of the cellular RNA-induced silencing complex (RISC)Potential for systemic inflammatory responses to oligonucleotide deliveryUnintended phenotypic changes due to the broad regulatory network of a single miRNA
06

Interacting drugs

miR-135a-5p mimic

2 more in the full profile.

07

Biomarkers

miR-135a-5p expression levelTarget mRNA levels (e.g., ROCK1, HOXA10, SIRT1)Target protein expression

Beyond the preview

Go deeper on MicroRNA 135a-5p target messenger RNAs (miR-135a-5p targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 135a-5p target messenger RNAs (miR-135a-5p targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call